Form 4: UL Solutions Director Michael Thaman Reports Routine Acquisition of Dividend Equivalent Rights

Sentiment:

Insider Transaction Report


UL Solutions Inc. Director Michael H. Thaman reported the acquisition of 5 dividend equivalent rights associated with his restricted stock units, bringing his total beneficial ownership to 2,792 derivative securities.

Summary

  • Michael H. Thaman, a Director of UL Solutions Inc. (ULS), reported a transaction on June 9, 2025, involving the acquisition of 5 dividend equivalent rights.
  • These dividend equivalent rights are economically equivalent to one share of UL Solutions' Class A Common Stock each.
  • The acquisition represents the routine accrual of dividend equivalent rights on restricted stock units already held by Mr. Thaman.
  • Following this transaction, Mr. Thaman's total beneficial ownership of derivative securities, which includes restricted stock units and all accrued dividend equivalent rights, stands at 2,792.
  • The dividend equivalent rights vest proportionately with the underlying restricted stock units, which are scheduled to vest on the earlier of May 20, 2026, or the date of the annual meeting following their grant date.
  • For future reporting, dividend equivalent rights will be aggregated with the underlying restricted stock units in Form 4 filings.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The filing reports a routine accrual of dividend equivalent rights, which is an expected part of equity compensation. It signals continued director alignment with shareholder interests but does not indicate significant new developments.

Positives

  • The acquisition of dividend equivalent rights indicates the company's continued distribution of value to equity holders, even for unvested awards, which is a standard practice for equity compensation.
  • The director's continued beneficial ownership, including accrued rights, aligns management interests with shareholder value.

Future Outlook

The document indicates that dividend equivalent rights will continue to be reported aggregated with the underlying restricted stock units in future filings. The vesting of the underlying restricted stock units and associated dividend equivalent rights is expected by May 20, 2026, or the next annual meeting following the grant date.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically the accrual of dividend equivalent rights on existing equity awards. Such filings are common across all publicly traded companies and reflect standard executive compensation practices involving equity awards, rather than providing broader industry-specific context.

Comparison to Industry Standards

  • The reporting of dividend equivalent rights as part of restricted stock unit compensation is a common practice in executive compensation across various industries, aligning with typical equity incentive structures.
  • The aggregation of dividend equivalent rights with underlying restricted stock units for reporting purposes, as noted in the filing, streamlines disclosure and is consistent with evolving SEC reporting interpretations for such awards.

Stakeholder Impact

  • Shareholders: The filing provides transparency regarding director equity holdings and the accrual of benefits, reinforcing alignment between management and shareholder interests.
  • Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

  • Continued reporting of dividend equivalent rights aggregated with underlying restricted stock units in future Form 4 filings.
  • Vesting of the restricted stock units and associated dividend equivalent rights on the earlier of May 20, 2026, or the date of the annual meeting following the grant date.

Key Dates

DateDescription
06/09/2025Date of earliest transaction (acquisition of dividend equivalent rights).
06/11/2025Signature date of the Form 4 filing.
05/20/2026Earliest potential vesting date for restricted stock units and associated dividend equivalent rights.

Recommendation

hold

Keywords

UL Solutions, ULS, Form 4, Insider Transaction, Director, Michael Thaman, Restricted Stock Units, Dividend Equivalent Rights, Beneficial Ownership, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.